iSpecimen Inc. Annual Meeting of Stockholders December 30, 2026
iSpecimen Inc. has scheduled its 2026 annual meeting of stockholders for December 30, 2026 at 3:00 p.m. Eastern Time as a virtual meeting. The proxy statement asks stockholders to vote on four proposals: election of Avtar Dhaliwal as Class II director, ratification of Bush & Associates CPA LLC as auditor for 2026, approval of reincorporation from Delaware to Nevada, and a potential adjournment proposal. The Board unanimously recommends voting FOR all proposals.
Key takeaways
Annual meeting scheduled for December 30, 2026 at 3:00 p.m. Eastern Time as a virtual meeting via www.virtualshareholdermeeting.com/ISPC2026; record date November 2, 2026
Proposal to elect Avtar Dhaliwal as Class II director for a three-year term expiring at the 2029 annual meeting
Proposal to ratify Bush & Associates CPA LLC as independent registered public accounting firm for fiscal year ending December 31, 2026
Proposal to approve reincorporation from Delaware corporation to Nevada corporation pursuant to a Plan of Conversion
Leadership transition: Shahin Behroyan appointed CEO on August 26, 2026, succeeding Katharyn Field who transitioned from the role
Nasdaq listing risk: Company received notice on May 29, 2026 of non-compliance with minimum stockholders' equity requirement of $2,500,000; extension granted until November 25, 2026
Special meeting on October 9, 2026 approved Foldlab AI asset acquisition for $4,500,000 ($2,000,000 cash and $2,500,000 in common stock)
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow ISPC in real time
Get material earnings, filing, IR, and earnings-call alerts by email.